Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species

被引:249
作者
Borman, Andrew M. [1 ]
Szekely, Adrien [1 ]
Johnson, Elizabeth M. [1 ]
机构
[1] Publ Hlth England South West, UK Natl Mycol Reference Lab MRL, Bristol, Avon, England
来源
MSPHERE | 2016年 / 1卷 / 04期
关键词
pathogenicity; Candida auris; pathogenic yeasts; emerging pathogen; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ANTIFUNGAL SUSCEPTIBILITY; AMPHOTERICIN-B; CLONAL STRAIN; HAEMULONII; EPIDEMIOLOGY; IDENTIFICATION; SURVEILLANCE; INFECTIONS;
D O I
10.1128/mSphere.00189-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida auris, first described in 2009, has since emerged as an important, multidrug-resistant, nosocomial agent of candidemia, with large outbreaks reported worldwide and high mortality rates associated with therapeutic failure. The current study employed C. auris isolates from a variety of centers in the United Kingdom to evaluate the pathogenicity of this emerging pathogen compared to that of other common pathogenic yeast species in the invertebrate Galleria mellonella infection model. We showed that C. auris isolates differ in their growth characteristics in vitro, with a proportion of isolates failing to release daughter cells after budding, resulting in the formation of large aggregates of cells that cannot be physically disrupted. Our results also demonstrate strain-specific differences in the behavior of C. auris in G. mellonella, with the aggregate-forming isolates exhibiting significantly less pathogenicity than their nonaggregating counterparts. Importantly, the nonaggregating isolates exhibited pathogenicity comparable to that of C. albicans, which is currently accepted as the most pathogenic member of the genus, despite the fact that C. auris isolates do not produce hyphae and produce only rudimentary pseudohyphae either in vitro or in G. mellonella. IMPORTANCE The incidence of invasive candidiasis, which includes candidemia and deep tissue infections, continues to rise and is associated with considerable mortality rates. Candida albicans remains the most common cause of invasive candidiasis, although the prevalence of non-albicans species has increased over recent years. Since its first description in 2009, Candida auris has emerged as a serious nosocomial health risk, with widespread outbreaks in numerous hospitals worldwide. However, despite receiving considerable attention, little is known concerning the pathogenicity of this emerging fungal pathogen. Here, using the Galleria mellonella insect systemic infection model, we show strain-specific differences in the virulence of C. auris, with the most virulent isolates exhibiting pathogenicity comparable to that of C. albicans, which is currently accepted as the most pathogenic member of the genus.
引用
收藏
页数:8
相关论文
共 26 条
  • [1] [Anonymous], 2008, Approved standard M27-A. A National Committee for Clinical Laboratory Standards
  • [2] Epidemiology, Antifungal Susceptibility, and Pathogenicity of Candida africana Isolates from the United Kingdom
    Borman, Andrew M.
    Szekely, Adrien
    Linton, Chistopher J.
    Palmer, Michael D.
    Brown, Phillipa
    Johnson, Elizabeth M.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (03) : 967 - 972
  • [3] Multidrug-resistant endemic clonal strain of Candida auris in India
    Chowdhary, A.
    Kumar, V. Anil
    Sharma, C.
    Prakash, A.
    Agarwal, K.
    Babu, R.
    Dinesh, K. R.
    Karim, S.
    Singh, S. K.
    Hagen, F.
    Meis, J. F.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (06) : 919 - 926
  • [4] New Clonal Strain of Candida auris, Delhi, India
    Chowdhary, Anuradha
    Sharma, Cheshta
    Duggal, Shalini
    Agarwal, Kshitij
    Prakash, Anupam
    Singh, Pradeep Kumar
    Jain, Sarika
    Kathuria, Shallu
    Randhawa, Harbans S.
    Hagen, Ferry
    Meis, Jacques F.
    [J]. EMERGING INFECTIOUS DISEASES, 2013, 19 (10) : 1670 - 1673
  • [5] Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x
  • [6] Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database
    Fraser, Mark
    Brown, Zoe
    Houldsworth, Marian
    Borman, Andrew M.
    Johnson, Elizabeth M.
    [J]. MEDICAL MYCOLOGY, 2016, 54 (01) : 80 - 88
  • [7] Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry
    Girard, Victoria
    Mailler, Sandrine
    Chetry, Marion
    Vidal, Celine
    Durand, Geraldine
    van Belkum, Alex
    Colombo, Arnaldo L.
    Hagen, Ferry
    Meis, Jacques F.
    Chowdhary, Anuradha
    [J]. MYCOSES, 2016, 59 (08) : 535 - 538
  • [8] Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method
    Kathuria, Shallu
    Singh, Pradeep K.
    Sharma, Cheshta
    Prakash, Anupam
    Masih, Aradhana
    Kumar, Anil
    Meis, Jacques F.
    Chowdhary, Anuradha
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (06) : 1823 - 1830
  • [9] Candida haemulonii and Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features
    Kim, Mi-Na
    Shin, Jong Hee
    Sung, Heungsup
    Lee, Kyungwon
    Kim, Eui-Chong
    Ryoo, Namhee
    Lee, Jin-Sol
    Jung, Sook-In
    Park, Kyung Hwa
    Kee, Seung Jung
    Kim, Soo Hyun
    Shin, Myung Geun
    Suh, Soon Pal
    Ryang, Dong Wook
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (06) : e57 - e61
  • [10] Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis
    Kumar, Dharmendra
    Banerjee, Tuhina
    Pratap, Chandra Bhan
    Tilak, Ragini
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (04): : 435 - 437